Cargando…
Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
Autores principales: | Wei, Shuang, Zhang, Zun-yi, Fu, Sheng-ling, Xie, Jun-gang, Liu, Xian-sheng, Xu, Yong-jian, Zhao, Jian-ping, Xiong, Wei-ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347590/ https://www.ncbi.nlm.nih.gov/pubmed/30683838 http://dx.doi.org/10.1038/s41419-019-1300-3 |
Ejemplares similares
-
Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2016) -
Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2017) -
Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2018) -
Retraction Note: Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548
por: Jin, Mingming, et al.
Publicado: (2023) -
Retraction Note: Hsa-miR-520d induces hepatoma cells to form normal liver tissues via a stemness-mediated process
por: Tsuno, Satoshi, et al.
Publicado: (2018)